ascular endothehal as well as smooth muscle cells (SMCs) are known to synthesize mtrlc oxide (NO), a labile free radical and intracellular messenger with a half-life of a few seconds I,* NO 1s synthesized by oxldatlon of the terminal guamdmo-nitrogen atoms of L-argmme by a family of enzymes called NO synthase (NOS) ' * Within the vessel wall, two distinct types of NOS have been identified The first 1~ a constltutlve Ca*+-dependent and calmodulm-dependent membrane-bound form that 1s present m endothehal cells and plays an important role m the dynamic control of vascular tone The second 1s an inducible Ca*+-independent form that IS mduced by endotoxm and some cytokmes and 1s present m vascular SMCs ' * Endothehal cells contmuously generate low levels of NO, which maintain homeostasls m normal blood vessels I-? In contrast to endothehal cells, SMCs generate large amounts of NO m response to cytokmes and endotoxm In SMCs, cyclic AMP and agents that increase cellular cyclic AMP levels (eg, forskolm and lsopreterenol) induce 1NOS expression and NO synthesis, as well as enhance cytokmeInduced NO synthesis m SMCs, by stablhzmg 1NOS mRNA 4mh Since adenosme stimulates cychc AMP levels m vascular SMCs via A, receptors,' we hypothesize that adenosine may induce NO synthesis m vascular SMCs and enhance cytokme induced NO synthesis (Fig 1) Recent studies from our laboratory demonstrate that In vascular SMCs cychc AMP 1s an important determinant of adenosme production via a blochenucal mechanism we refer to as the cychc AMP-adenosme pathway (Fig 1) B This pathway mvolves the conversion of cychc AMP to AMP, and, hence, to adenosme by the enzymes phosphodlesterase (PDE) and S'-nucleotldase, respectively The cychc AMP-adenosme pathway may have both intracellular and extracellular arms, le. adenosme might be formed within the cell and transported to the extracellular space, or it might be formed directly m the extracellular space * We have recently shown that the mhlbltory effects of cychc AMP on SMC prollferatlon are blocked by A, adenoqme receptor antagomsts,8 thus lmplymg that the cychc AMP-adenosme pathway regulates SMC growth Since cychc AMP 1s a precursor for adenosmeX and adenosme may Induce NO synthesis, we hypothesize that the cychc AMPadenosme pathway may be a potential pathway m regulating NO synthesis m vascular SMCs (Fig 1) Dubey et al After adding fresh 0.5 mL of homogenization buffu, the SMC? were scraped and transfered into Eppendorf tubes. The cells were then lysed by sonication and the cell cytosols extracted fi-om the lysates by centrifugation at 20002 for 10 minutes at 4'C, followed by centrif~lgation at 10 0002 for 15 minutes at 4°C. Aliquots (30 FL) of the rewlting cytosolq were subsequently incubated in the presence or absence of L-NAME
(1 mmol/L) or EDTA (1 mmol/L) for 30 minutes at 37'C with a reaction mixture containing (Fig 2A) , and the release of nitrite/nitrate in response to LPS was enhanced in a concentratior-dependent manner by Cl-Ad (Fig 2A) . In the presence of L-NAME, Cl-Ad, LPS and LPS plus Cl-Ad did not increase nitrite/nitrate levels (Fig 2A) . receptors and not via A, or A?, receptors. These findings provide evidence that exogenous as well as SMC-derived adenosine induces NO synthesis in an autocrine/paracrine fashion and via the A2,1 receptor. The present study also establishes that treatment of SMCs with cyclic AMP, a precursor of adenosine, stimulates NO synthesis. Moreover, the stimulatory effects of cyclic AMP are blocked by KF17837 and DPSPX, but not by DPCPX. These findings suggest that cyclic AMPderived adenosine induces NO-synthesis via A,, receptors. Finally, our studie$ show that the stimulation of NO synthesis by exogenous and endogenous adenosine is not blocked by DDA, an adenylyl cyclase inhibitor," or RpcAMP, a preferential inhibitor of cyclic AMP-dependent protein kinase. ' ' These findings suggest that adcnosine induces NO synthesis via a pathway that does not involve adenylyl cyclare/protein kinase A.
Local generation of NO within blood vessels plays a key role in the biology, physiology, and pathophysiology of the vasculature.'-' NO generated luminally prevents platelet aggregation and adhesion, as well as neutrophil-induced damage to endothelial cells.'-" When generated abluminally, NO activates soluble guanylyl cyclase in SMCs, and thereby increases cGMP levels, decreases intracellular Ca'+ levels, induces vasodilation, and inhibits proliferation and migration of SMCs.'-','I Under basal conditions cNOS within the endothelial cells is the main source for NO synthesis, whereas under pathological conditionc, such as sepsis, iNOS within the SMCs plays a key role in inducing hypotension."
In addition to NO, there are several other vasodilatory factors that regulate the vascular function in an autocrine/paracrine iashion." Moreover, many of these Eactors are now known to induce their effects via generation of etidothelium-derived NO.'-" In this regard, recent studies have shown that adenosine, which mimicks most of the antivatoocclu<lve effects of N0,j,12 rtnnulates NO synthevlr by vascular endothehal cells via A, receptor$. '3,'4 Although the vascular effects of adenoyme may, m part, be mediated via endothehal cell-derived NO, adenoTme induces va?odilation both m the presence and absence of the endothelium." However, the mechamcmc for the endothehum-Independent dilatory effects adenosme are not fully understood. Recent studies show that teveral endogenous vasodllatory factors stmm!ate NO Fynthesis by SMCs. In this regard, cyclic AMP, as well as agents that elevate cychc AMP levels, Induce NO synthesis by SMCY and mesanglal cells via lNOS stmlulatlon.4-" '(, Because treatment of SMCs with adenosme mcrea<er mtracellular cychc AMP levels,' we hypothe$lzed that adenosme mducer NO rynthesls m vascular SMCs. The findmgc that adenosme and its stable analog, Cl-Ad, stimulate mtrite/mtrate cynthe$ls and 'H-L-citrullme formation by SMCc and that thic stlmulatlon 15 inhibited by L-NAME provides evidence that adenocme mduces NO syntheqs m SMCs. Moreover, the observation that EDTA does not inhibit 'H-L-citrulhne formation suggests that adenosme induces NO synthesis via 1NOS. Conylstent with this conclusion, Ikeda et a1.17 very recently published a report that Cl-Ad mducey 1NOS mRNA m rat vascular SMCs, thur confirmmg our prevlouslx and present findings that, via 1NOS ytmiulatlon, adenosme induce? NO synthesl$ m SMCs.
Our observations that CPA (adenosme analog selective for A, receptors at pharmacologically low doses [<I nmol/L]') 1s unable to induce NO Tynthesis at low concentrations and DPCPX (selective A, adenosine receptor antagonist) does not block the $tnnulatoiy effects of Cl-Ad on NO gynthe?lr suggest that the stimulatory effect\ of adenosme are not mediated via A, receptors. Our findings that KF17837 and DPSPX, both A, receptor antagomstc, but not DPCPX, attenuate the stmiulatory effects of Cl-Ad suggest that the stlmulatory effects of adenosine are Az receptor mediated. Moreover, our ob?ervation that only high, but not low, concentrations of CGS21680, an adenosme agonist which 1s highly selective for AZA receptors at concentrations of <IO mnol/L, stimulates NO synthecl?, provides evidence that the effects of adenosme are not mediated via AzA receptors. Rather, our data Tuggectu that the AZ" receptors may be mvolved m medlatmg the stmiulatory effects of adenosine.
The above findings provide clear evidence that exogenous adenosme stimulates NO syntheslc by SMCs; however, whether endogenous adeno$me has snnilar stnnulatory effects cannot be inferred from studies with agomrts. Elimmatlon of adenosine from the interstitial Tpace 1s mediated by faclhtated transport of adenosine mto cells followed by metabohrm of adenosme to mosine by adenosme deammate and to AMP by adenosme kinase.'2 Inhibltlon of adenonne deaminase by EHNA and adenosme kmase by ID0 mcrease? endogenous levels of adenocme.'" Moreover, we have shown that EHNA and ID0 increase adenosme levels in cultured SMCrS and cardiac fibroblasts."' Hence, these two compounds were used m the present study to assess the role of endogenous, le, SMC-derived, adenosine on NO rynthesls. EHNA and ID0 mcrea$e NO synthesis m SMCY, and the stlmulatory effects of EHNA and ID0 are slgmficantly en-hanced when SMCs are treated with a combmatlon of these agents Moreover, the stlmulatory effects of EHNA and ID0 on NO synthesis are blocked by L-NAME, but not by EDTA, suggesting that SMC NO 1s derived from lNOS The AZ receptor blockers, KF17837 and DPSPX, significantly attenuate the stlmulatory effects of EHNA plus IDO, supportmg our contention that the stlmulatory effects of these agents on NO synthesis m SMCs are mediated via generation of adenosme Moreover, the finding that DPCPX does not reverse the stlmulatory effects of EHNA plus ID0 on SMCs strongly suggests that the stlmulatory effects of endogenous adenosme are mediated via A2 receptors Formation of adenosme wlthm and/or near the blood vessel wall occurs via three blochemlcal pathways (1) the mtracellular ATP pathway, which entails intracellular dephosphorylanon of ATP to adenosme, (2) the extracellular ATP pathway, which 1s a source of extracellular adenosme, (3) the transmethylatlon pathway, which mvolves the hydrolysis of S-adenosyl-L-homocysteme (SAH) to L-homocysteme and adenosme 8,12,1'1 Smce the intracellular and extracellular ATP pathways of adenosme production reqmre crlsls events and the transmethylatlon pathway 1s mostly constltutlve, the three tradltlonal routes of adenosme blosynthesls are not well suited for physlologlcal modulation
More recently, we have demonstrated the presence of a fourth pathway, the cychc AMPadenosme pathway, for adenosme production m vascular SMCs* that would be more amenable to physlologlcal modulation by hormones
The cychc AMP-adenosme pathway begms with the actlvatlon of adenylyl cyclase and has both intracellular and extracellular sites of adenosme production * Wlthm the cell, cytosohc PDE and cytosohc 5'-nucleotldase metabolize cychc AMP to AMP and AMP to adenosme, respectively, and the adenosme formed reaches the extracellular space via faclhtated transport *,I* However, due to the competltlon of cytosohc 5'-nucleotldase and adenylate kmase for AMP and the competltlon of transport mechanisms with adenosme kmase for adenosme, the intracellular formation of adenosme may be dlmmlshed R l2 Therefore, the extracellular hmb of the cychc AMP-adenosme pathway, which mvolves the efficient metabolism of cychc AMP to AMP and adenosme by ecto-PDE and ecto-5'-nucleotldase, respectively, may be quantltatlvely more important 8 I2
Regarding the extracellular cychc AMP-adenosme pathway, stimulation of adenylyl cyclase results m egress of cychc AMP,8,'2 and relatively modest increases m cychc AMP production could give rise to slgmficant concentrations of adenosme at the cell surface, smce adenosme would be synthesized by a series of spatially linked enzymatic reactions * I2 We have recently shown that SMCS,~ mesangal cellQ" and cardiac fibroblasts*l express the extracellular hmb of the cychc AMP-adenosme pathway Moreover, m all these cell types1 cychc AMP-derived adenosme mhlblts mltogeninduced cell growth. ?,** These studies led us to hypothesize that the cychc AMP-adenosme pathway may also induce NO synthecls m SMCs To test this hypothesis, we evaluated the effects of cychc AMP on NO synthesis m the presence and absence of the A, specific and nonspecific receptor antagonists, KF17837 and DPSPX, respectively, and the A, adenosme receptor antagonist, DPCPX Cychc AMP stmlulates NO production by SMCs, and the stlmulatory effect of cychc AMP on NO synthesis 1s sign& cantly attenuated by the adenosme receptor antagonists KF17837 and DPSPX, but not by DPCPX, quggestmg the mvolvement of A, receptor5 This conclusion 1s consistent with our observations that the stlmulatory effects of exogenous and endogenous adenosme on NO synthesis by SMCs are medlated via A, receptors and are blocked by KF17837 and DPSPX Taken together these findings strongly suggest that the cychc AMP-adenosme pathway may contribute lmportantly to the regulation of vascular biology and more speclficaliy NO synthesis by SMCY Although these findings provide evidence for the role of exogenous, endogenous, and cychc AMP-derived adenosme m mducmg NO synthesis by SMCr, the mechanisms involved m this effect are unclear Our data provides evidence that the effects of adenosme are mediated via AZ receptors Smce AZ receptors are posltlvely coupled to adenylyl cyclase and cychc AMP mducec NO qynthesls m SMCs by mcreasmg lNOS activity, It 1s feasible that the stlmulatory effects of adenosme on NO synthesis by SMCs 1s medlated largely via the second messenger cychc AMP However, neither DDA, an mhlbltor of adenylate cyclase that blocks cychc AMP generation, nor Rp-CAMP, an mhlbltor of cychc AMP-dependent kmase, block the stmmlatory effects of either adenocme or EHNA plus ID0 on NO synthesis These findings cuggest that the stlmulatory effects of exogenous as well as SMC-denved adenosme on NO synthesis are mediated via A, adenosme receptor? linked to a pathway not mvolvmg adenylyl cyclase/protem kmase A
In conclusion, we provide evidence that both exogenous and vascular SMC-derived adenosme induces NO synthesis by vascular SMCs m an autocrme fashion As the effects of exogenous and endogenous adenosme on "H-L-cltrullme folmatlon are not blocked by EDTA, the stlmulatory effects of adenosme are most likely mediated via lNOS Moreover, our findings provide evidence that adenosme generated from cychc AMP stimulates NO synthesis by SMCs m an autocrme/ paracrme fashion Since both adenosme and NO induce vasodllatlon, mhlblt platelet aggregation and adhesion, and prevent mltogen-induced prohferatlon and mlgratlon of SMCs,'e3 '* processes importantly Involved m vaso-occlusive disorders m various vascular diseases, the current findmgq suggest that adenosme produced by SMCs may play a vital role as a local anti-vasooccluclve agent, which may induce Its effect? m part via generation of NO locally wlthm the vessel wall Moreover, decreased SMC synthesis of adenosme or increased catabolism of adenosme by adenosme deammase or adenosme kmase may importantly contribute to decreased qynthesls of NO This may m turn be associated with abnormal growth of SMCs and the vascular remodeling and vaso-occlu5lve dlsorders observed m hypertension, atherosclerosis, and restenoslq followmg balloon angloplasty 3 '* Agents that elevate endogenous adenosme could be chmcally important m preventing vaso-occlusive disorders associated with hypertension, atherosclerosis, and restenosls by mducmg NO synthesis wlthm the vasculature, thus exerting beneficial effects on the vessel wall CAMP-Adenosme Pathway Induces NO Synthesis Finally, it IS possible that the cychc AMP-adenosme pathway may Importantly regulate vascular biology and physiology m VlVO
